Financials data is unavailable for this security.
Cash flow in CADView more
In 2023, cash reserves at Cytophage Technologies Ltd fell by 2.21m. Cash Flow from Financing totalled 3.26m or -- of revenues. In addition the company used 2.86m for operations while cash used for investing totalled 2.62m.
Cash flow per share | -0.2376 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0978 |
---|---|
Tangible book value per share | 0.0978 |
More ▼
Balance sheet in CADView more
Current ratio | 5.88 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.3113 |
---|---|
Total debt/total capital | 0.2374 |
More ▼